<code id='132D6B36DD'></code><style id='132D6B36DD'></style>
    • <acronym id='132D6B36DD'></acronym>
      <center id='132D6B36DD'><center id='132D6B36DD'><tfoot id='132D6B36DD'></tfoot></center><abbr id='132D6B36DD'><dir id='132D6B36DD'><tfoot id='132D6B36DD'></tfoot><noframes id='132D6B36DD'>

    • <optgroup id='132D6B36DD'><strike id='132D6B36DD'><sup id='132D6B36DD'></sup></strike><code id='132D6B36DD'></code></optgroup>
        1. <b id='132D6B36DD'><label id='132D6B36DD'><select id='132D6B36DD'><dt id='132D6B36DD'><span id='132D6B36DD'></span></dt></select></label></b><u id='132D6B36DD'></u>
          <i id='132D6B36DD'><strike id='132D6B36DD'><tt id='132D6B36DD'><pre id='132D6B36DD'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:3326
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Argenx drug significantly slows progression of nerve disorder
          Argenx drug significantly slows progression of nerve disorder

          AdobeBelgiandrugmakerArgenxsaidMondaythatitsantibodytreatmentcalledVyvgartsignificantlydelayedthepro

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

          5:16FormerPresidentandRepublicanpresidentialcandidateDonaldTrumptakesthestageduringtheTurningPointAc